Semaglutide treatment sparked an average weight loss of 11 pounds over 12 weeks.
Diabetes
Latest News
Advertisement
CME Content
Advertisement
When pharmacists promote behavioral changes, it encourages positive patterns that last a lifetime.
Does this antihyperglycemic combination medication need to be added to a formulary?
A growing body of data show that type 2 diabetes is at least in part rooted in inflammation, said Edgar Engleman, MD, a professor of pathology and medicine at Stanford University.
Patients with diabetes may have a higher risk of heart disease due to hyperactive mTORC1.
Financial rewards may be an effective way to get young patients with diabetes to achieve blood glucose targets.
Inhibiting a protein may reduce symptoms of diabetic retinopathy.
Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.
Rigorous screening guidelines can reduce the number of undiagnosed cases of diabetes.
Top articles of the week from The American Journal of Pharmacy Benefits.
Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes.
Pregnant women who slept less than 6.5 hours per night were nearly 3 times as likely to develop gestational diabetes.
Top news of the day from across the healthcare landscape.
Top news of the day from across the healthcare landscape.
Deleting fatty acid-binding proteins may lead to lifelong metabolic health.
Which OTC products should these pharmacists recommend?
Researchers have augmented insulin’s effectiveness with several rapid and long-acting analogs and new delivery systems, such as insulin pens and insulin pumps.
The number of diabetes cases continues to soar, with the latest data showing that an estimated 30.3 million Americans have the disease.
The increasing incidence of diabetes is outpacing the number of health care providers skilled in caring for affected patients.
PPARγ agonists may improve outcomes for patients with acute myeloid leukemia.
Patients treated with Bydureon BCise had an average HbA1c reduction of 1.4% after 28 weeks.
Antibiotics were previously thought to increase the incidence of certain autoimmune diseases.
Top articles of the week from The American Journal of Pharmacy Benefits.
A ketogenic state may provide benefits for patients with diabetes.
Once-weekly injection of semaglutide recommended for approval for improved glycemic control in adults with type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
From Mutation to Medicine: Targeted Therapies in Lung Cancer
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5
